Achieve Life Sciences Inc (ACHV)

HEALTH CARE: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

22722 29TH DR. SE SEATTLE, WA 98021

Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide. and nearly half a million deaths in the U.S. annually.12 More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke. Achieve's focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline. Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in smoking cessation by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and by reducing the reward and satisfaction associated with smoking.

Data as of 2021-10-17 09:23:38 -0400
Market Cap76.09 Million Shares Outstanding9.452 Million Avg 30-day Volume105.596 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.71 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.00587 52-week High/Low16.1 / 6.63 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -4.3409
Data provided by IEX Cloud
View SEC Filings from ACHV instead.

View recent insider trading info

Funds Holding ACHV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACHV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JACOBS CINDY PRESIDENT & CMO

  • Officer
  • Director
223 2021-08-17 3

BENCICH JOHN CEO

  • Officer
  • Director
6,188 2021-08-17 4

WAN JERRY PRINCIPAL ACCOUNTING OFFICER

  • Officer
94 2021-08-17 3

MOYES JAY M

  • Director
3,750 2021-05-11 1

MATTINGLY MARTIN A

  • Director
3,750 2021-05-11 1

JOSEPH DONALD

  • Director
3,750 2021-05-11 1

MARTELL BRIDGET A

  • Director
0 2021-03-15 2

CLARKE ANTHONY CSO

  • Officer
0 2021-01-26 2

STEWART RICHARD ALISTAIR EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2021-01-26 2

PARKER H STEWART

  • Director
0 2020-05-12 0

CORMACK SCOTT DANIEL

  • Director
0 2020-05-12 0

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • 10% Owner
No longer subject to file 2019-06-11 0

SCHACTER ROBERT

  • 10% Owner
1,827,426 2017-08-01 0

SMITH DAVID V

  • Director
0 2016-05-26 0

GOLDSTEIN JACK

  • Director
0 2016-05-26 0

CLENDENINN NEIL JAMES

  • Director
0 2016-05-26 0

WYRICK SUSAN D. PAO

  • Officer
1,312 2014-03-14 0

BURRIS MICHELLE CFO

  • Officer
0 2012-05-08 0

LAWRENCE CAMERON WILLIAM PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2012-05-08 0

MARTINO MICHAEL A

  • FORMER DIRECTOR
11,000 2010-07-06 0

WINSTEAD DWIGHT

  • Director
0 2010-05-13 0

ANDERSON STEPHEN CHARLES CFO AND SECRETARY

  • Officer
0 2009-12-31 0

BRADY PATRICK ROBERT

  • Director
No longer subject to file 2009-12-22 0

H.I.G. ONCOGENEX, INC.

H.I.G. KEY CORP

H.I.G. HORIZON CORP

MNAYMNEH SAMI

TAMER ANTHONY

  • 10% Owner
No longer subject to file 2009-06-03 0

VENTURES WEST CAPITAL LTD

  • 10% Owner
476,819 2008-12-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 22:15:03 UTC -1.8226 1.8926 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 21:45:03 UTC -1.8226 1.8926 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 21:15:03 UTC -1.8226 1.8926 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 20:45:03 UTC -2.0537 2.1237 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 20:15:03 UTC -2.0537 2.1237 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 19:45:03 UTC -2.0537 2.1237 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 19:15:03 UTC -2.0537 2.1237 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 18:45:03 UTC -2.0455 2.1155 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 18:15:03 UTC -2.0455 2.1155 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 17:45:03 UTC -2.0455 2.1155 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 17:15:03 UTC -2.0455 2.1155 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 16:45:03 UTC -2.0455 2.1155 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 16:15:04 UTC -2.0455 2.1155 400000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 15:45:03 UTC -2.0455 2.1155 350000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 15:15:03 UTC -2.0455 2.1155 350000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 14:45:03 UTC -2.0176 2.0876 350000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 14:15:03 UTC -2.0176 2.0876 350000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 13:45:03 UTC -2.0176 2.0876 350000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 13:15:03 UTC -2.0176 2.0876 350000
ACHIEVE LIFE SCIENCES INC ACHV 2021-10-22 12:45:03 UTC -2.0176 2.0876 300000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Achieve Life Sciences Inc 0.6% 2020-08-12 GERMANY
Squarepoint Ops LLC Achieve Life Sciences Inc 0.53% 2020-08-11 GERMANY

Elevate your investments